These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 21651619

  • 1. Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients.
    Bjørneklett R, Vikse BE, Smerud HK, Bostad L, Leivestad T, Hartmann A, Iversen BM.
    Clin Transplant; 2011; 25(3):E356-65. PubMed ID: 21651619
    [Abstract] [Full Text] [Related]

  • 2. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.
    Moroni G, Longhi S, Quaglini S, Gallelli B, Banfi G, Montagnino G, Messa P.
    Nephrol Dial Transplant; 2013 May; 28(5):1305-14. PubMed ID: 23229925
    [Abstract] [Full Text] [Related]

  • 3. Favorable outcome of renal transplantation in patients with IgA nephropathy.
    Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF.
    Clin Nephrol; 2001 Oct; 56(4):279-88. PubMed ID: 11680657
    [Abstract] [Full Text] [Related]

  • 4. Recurrent IgA nephropathy in renal transplant allografts.
    Wang AY, Lai FM, Yu AW, Lam PK, Chow KM, Choi PC, Lui SF, Li PK.
    Am J Kidney Dis; 2001 Sep; 38(3):588-96. PubMed ID: 11532693
    [Abstract] [Full Text] [Related]

  • 5. The fate of renal transplants in patients with IgA nephropathy.
    Frohnert PP, Donadio JV, Velosa JA, Holley KE, Sterioff S.
    Clin Transplant; 1997 Apr; 11(2):127-33. PubMed ID: 9113449
    [Abstract] [Full Text] [Related]

  • 6. Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.
    Han SS, Huh W, Park SK, Ahn C, Han JS, Kim S, Kim YS.
    Transpl Int; 2010 Feb; 23(2):169-75. PubMed ID: 19761553
    [Abstract] [Full Text] [Related]

  • 7. Duration of end-stage renal disease and kidney transplant outcome.
    Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, Cheung AK.
    Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
    [Abstract] [Full Text] [Related]

  • 8. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
    Courtney AE, McNamee PT, Nelson WE, Maxwell AP.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
    [Abstract] [Full Text] [Related]

  • 9. IgA nephropathy recurs early in the graft when assessed by protocol biopsy.
    Ortiz F, Gelpi R, Koskinen P, Manonelles A, Räisänen-Sokolowski A, Carrera M, Honkanen E, Grinyó JM, Cruzado JM.
    Nephrol Dial Transplant; 2012 Jun; 27(6):2553-8. PubMed ID: 22167589
    [Abstract] [Full Text] [Related]

  • 10. Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
    Leeaphorn N, Garg N, Khankin EV, Cardarelli F, Pavlakis M.
    Transpl Int; 2018 Feb; 31(2):175-186. PubMed ID: 28926143
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.
    Namba Y, Oka K, Moriyama T, Ichimaru N, Kyo M, Kokado Y, Ito T, Imai E, Aozasa K, Okuyama A, Takahara S.
    Transplant Proc; 2004 Jun; 36(5):1314-6. PubMed ID: 15251321
    [Abstract] [Full Text] [Related]

  • 12. IgA NEPHROPATHY IN PATIENTS RECEIVING A RENAL TRANSPLANT.
    Lemes-Canuto AP, de Sandes-Freitas TV, Medina-Pestana JO, Mastroianni-Kirsztajn G.
    J Ren Care; 2015 Dec; 41(4):222-30. PubMed ID: 25819382
    [Abstract] [Full Text] [Related]

  • 13. Renal transplantation in patients with primary immunoglobulin A nephropathy.
    Choy BY, Chan TM, Lo SK, Lo WK, Lai KN.
    Nephrol Dial Transplant; 2003 Nov; 18(11):2399-404. PubMed ID: 14551373
    [Abstract] [Full Text] [Related]

  • 14. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.
    Clin Transplant; 2005 Nov; 19 Suppl 14():41-8. PubMed ID: 15955168
    [Abstract] [Full Text] [Related]

  • 15. Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation.
    Taber DJ, Meadows HB, Pilch NA, Chavin KD, Baliga PK, Egede LE.
    Clin Transplant; 2013 Nov; 27(2):274-82. PubMed ID: 23383719
    [Abstract] [Full Text] [Related]

  • 16. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A, Soltero L, Diná E, Alvarez-Sandoval E, Alberú J, Gamba G, Correa-Rotter R.
    Rev Invest Clin; 2002 Nov; 54(1):21-8. PubMed ID: 11995403
    [Abstract] [Full Text] [Related]

  • 17. The clinical course of IgA nephropathy after kidney transplantation and its management.
    Lionaki S, Panagiotellis K, Melexopoulou C, Boletis JN.
    Transplant Rev (Orlando); 2017 Apr; 31(2):106-114. PubMed ID: 28209246
    [Abstract] [Full Text] [Related]

  • 18. Impact of the pre-transplant histological score on 3-year graft outcomes of kidneys from marginal donors: a single-centre study.
    Carta P, Zanazzi M, Caroti L, Buti E, Mjeshtri A, Di Maria L, Raspollini MR, Minetti EE.
    Nephrol Dial Transplant; 2013 Oct; 28(10):2637-44. PubMed ID: 23904398
    [Abstract] [Full Text] [Related]

  • 19. Increased glomerulonephritis recurrence after living related donation.
    Kennard AL, Jiang SH, Walters GD.
    BMC Nephrol; 2017 Jan 17; 18(1):25. PubMed ID: 28095803
    [Abstract] [Full Text] [Related]

  • 20. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function.
    Bleskestad IH, Bergrem H, Leivestad T, Hartmann A, Gøransson LG.
    Clin Transplant; 2014 Apr 17; 28(4):479-86. PubMed ID: 25649861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.